The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation
Open accessAbstract
Treatment with iron chelators mimics hypoxic induction of the hypoxia inducible factor (HIF-1) which activates transcription by binding to hypoxia responsive elements (HRE). We investigated whether HIF-1 is involved in transcriptional activation of the transferrin receptor (TfR), a membrane protein which mediates cellular iron uptake, in response to iron deprivation. The transcription rate of the TfR gene in isolated nuclei was up-regulated by treatment of Hep3B human hepatoma cells with the iron chelator desferrioxamine (DFO). The role of HIF-1 in the activation of TfR was indicated by the following observations: (i) DFO-dependent activation of a luciferase reporter gene in transfected Hep3B cells was mediated by a fragment of the human TfR promoter containing a putative HRE sequence; (ii) mutation of this sequence prevented stimulation of luciferase activity; (iii) binding to this sequence of HIF-1alpha, identified by competition experiments and supershift assays, was induced by DFO. Furthermore, in mouse hepatoma cells unable to assemble functional HIF-1, inducibility of TfR transcription by DFO was lost and TfR mRNA up-regulation was reduced. These results, which show the role of HIF-1 in the control of TfR gene expression in conditions of iron depletion, give insights into the mechanisms of transcriptional regulation which concur with the well-characterized post-transcriptional control of TfR expression to expand the extent of response to iron deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The GAA triplet-repeat expansion in the frataxin gene was shown to interfere with frataxin gene transcription (223) because of a self-associated triplex formation at long GAA:TTC repeats (sticky DNA) (22, 193, 267, 268).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Purification and Characterization of Hypoxia-inducible Factor 1
Wang, G. L., & Semenza, G. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1230 · Cited by 2,094
Hentze, M. W., & Kühn, L. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8175 · Cited by 1,292
Regulating the fate of mRNA: the control of cellular iron metabolism
Klausner, R. D., Rouault, T. A., & Harford, J. B. (1993) · Cell · doi:10.1016/0092-8674(93)90046-s · Cited by 1,210
Oxygen sensing and molecular adaptation to hypoxia
Bunn, H. F., & Poyton, R. Ο. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.3.839 · Cited by 1,185
Lee, P. J., Jiang, B.-H., Chin, B. Y., Iyer, N. V., Alam, J., Semenza, G. L., & Choi, A. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5375 · Cited by 782
Ponka, P. (1997) · Blood · doi:10.1182/blood.v89.1.1 · Cited by 544
Oxygen(es) and the hypoxia-inducible factor-1.
Wenger, R. H., & Gassmann, M. (1997) · PubMed · Cited by 499
Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1
Rolfs, A., Kvietikova, I., Gassmann, M., & Wenger, R. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20055 · Cited by 401
Induction of Ferritin Synthesis by Oxidative Stress
Cairo, G., Tacchini, L., Pogliaghi, G., Anzon, E., Tomasi, A., & Bernelli‐Zazzera, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.700 · Cited by 322
Self-citation
Research works printed but not linked: 5
- Testa, 1993, Critical reviews in oncogenesis, 4, 241
- Hirsch, 1995, Cell Growth & Differentiation, 6, 719
- Wenger, 1997, Biological chemistry, 378, 609
- 1997, 113, 946
- 1992, 102, 802
Cited by
Sorted by citations
Hypoxia-Inducible Factor-1 (HIF-1)
Ke, Q., & Costa, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027029 · Cited by 1,690
Bao, S., Ouyang, G., Bai, X., Huang, Z., Ma, C., Liu, M., Shao, R., Anderson, R. M., Rich, J. N., & Wang, X.-F. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00081-9 · Cited by 561
Intracellular iron transport and storage: from molecular mechanisms to health implications
Mackenzie, E. L., Iwasaki, K., & Tsuji, Y. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1893 · Cited by 526
Gupta, N., & Wish, J. B. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.011 · Cited by 460
Earley, C. J., Connor, J. R., Garcı́a-Borreguero, D., Jenner, P. G., Winkelman, J. W., Zee, P. C., & Allen, R. P. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.05.009 · Cited by 343
The transferrin receptor: the cellular iron gate
Gammella, E., Buratti, P., Cairo, G., & Recalcati, S. (2017) · Metallomics · doi:10.1039/c7mt00143f · Cited by 324
Self-citationIron regulatory proteins in pathobiology
Cairo, G., & Pietrangelo, A. (2000) · Biochemical Journal · doi:10.1042/bj3520241 · Cited by 299
Self-citationEvstatiev, R., & Gasché, C. (2011) · Gut · doi:10.1136/gut.2010.214312 · Cited by 302
Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents
Candelaria, P. V., Leoh, L. S., Penichet, M. L., & Daniels‐Wells, T. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.607692 · Cited by 286
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
Richardson, D. R., Kalinowski, D. S., Lau, S. L., Jansson, P. J., & Lovejoy, D. B. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.04.003 · Cited by 260
A precious metal: Iron, an essential nutrient for all cells
Cairo, G., Bernuzzi, F., & Recalcati, S. (2006) · Genes & Nutrition · doi:10.1007/bf02829934 · Cited by 261
Self-citationThe hypoxia-inducible factors: key transcriptional regulators of hypoxic responses
Bracken, C. P., Whitelaw, M. L., & Peet, D. J. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2370-y · Cited by 259
Hypoxic preconditioning protects against ischemic brain injury
Sharp, F. R., Ran, R., Lu, A., Tang, Y., Strauss, K. I., Glass, T. F., Ardizzone, T. D., & Bernaudin, M. (2004) · NeuroRx · doi:10.1602/neurorx.1.1.26 · Cited by 242
Yoon, D., Pastore, Y. D., Divoký, V., Liu, E., Mlodnicka, A., Rainey, K., Poňka, P., Semenza, G. L., Schumacher, A., & Prchal, J. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602329200 · Cited by 231
Iron chelators as therapeutic agents for the treatment of cancer
Richardson, D. R. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00218-9 · Cited by 230
Ma, C., Rong, Y., Radiloff, D. R., Datto, M., Centeno, B. A., Bao, S., Cheng, A. W. M., Lin, F., Jiang, S., Yeatman, T. J., et al. (2008) · Genes & Development · doi:10.1101/gad.1632008 · Cited by 225
Olenyuk, B. Z., Zhang, G.-J., Klco, J. M., Nickols, N. G., Kaelin, W. G., & Dervan, P. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407617101 · Cited by 219
van den Berghe, P. V. E., Folmer, D. E., Malingré, H. E. M., van Beurden, E. A. C. M., KLOMP, A. E. M., van de Sluis, B., Merkx, M., Berger, R., & Klomp, L. W. J. (2007) · Biochemical Journal · doi:10.1042/bj20070705 · Cited by 218
Lawen, A., & Lane, D. J. R. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4271 · Cited by 221
Ryschich, E., Huszty, G., Knaebel, H. P., Härtel, M., Büchler, M. W., & Schmidt, J. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.036 · Cited by 199
Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators
Weinreb, O., Mandel, S. A., Youdim, M. B. H., & Amit, T. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.017 · Cited by 199
Graham, R. M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i35.4725 · Cited by 184
Cairo, G., Recalcati, S., Pietrangelo, A., & Minotti, G. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00825-0 · Cited by 176
Self-citationPathogenic implications of iron accumulation in multiple sclerosis
Williams, R., Buchheit, C. L., Berman, N. E. J., & LeVine, S. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07536.x · Cited by 171
Cold ischemic injury of transplanted kidneys: new insights from experimental studies
Salahudeen, A. K. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00098.2004 · Cited by 166
The Regulation of Cellular Iron Metabolism
Chua, A. C. G., Graham, R. M., Trinder, D., & Olynyk, J. K. (2007) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360701428257 · Cited by 172
Functional roles of transferrin in the brain
Leitner, D., & Connor, J. R. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.10.016 · Cited by 173
Rabinowitz, M. H. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400386j · Cited by 166
Hypoxia affects mesoderm and enhances hemangioblast specification during early development
Ramírez‐Bergeron, D. L., Runge, A., Dahl, K. D. C., Fehling, H. J., Keller, G. M., & Simon, M. C. (2004) · Development · doi:10.1242/dev.01310 · Cited by 153
Robach, P., Cairo, G., Gelfi, C., Bernuzzi, F., Pilegaard, H., Viganò, A., Santambrogio, P., Cerretelli, P., Calbet, J. A. L., Moutereau, S., et al. (2007) · Blood · doi:10.1182/blood-2006-08-040006 · Cited by 141
Self-citationOxygen‐dependent regulation of hypoxia‐inducible factors by prolyl and asparaginyl hydroxylation
Lando, D., Gorman, J. J., Whitelaw, M. L., & Peet, D. J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03445.x · Cited by 138
Minotti, G., Recalcati, S., Menna, P., Salvatorelli, E., Corna, G., & Cairo, G. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)78025-8 · Cited by 135
Self-citationTacchini, L., Gammella, E., De Ponti, C., Recalcati, S., & Cairo, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800365200 · Cited by 132
Self-citationClinkenbeard, E. L., Farrow, E., Summers, L. J., Cass, T. A., Roberts, J. L., Bayt, C. A., Lahm, T., Albrecht, M. E., Allen, M. R., Peacock, M., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2049 · Cited by 126
Iron-regulatory proteins: molecular biology and pathophysiological implications
Cairo, G., & Recalcati, S. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000531 · Cited by 124
Self-citationIron Regulatory Proteins: From Molecular Mechanisms to Drug Development
Recalcati, S., Minotti, G., & Cairo, G. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2983 · Cited by 127
Self-citationEffects of chronic hypoxia in vivo on the expression of human placental glucose transporters
Zamudio, S., Baumann, M. U., & Illsley, N. P. (2006) · Placenta · doi:10.1016/j.placenta.2004.12.010 · Cited by 114
Harada, H. (2016) · Journal of Radiation Research · doi:10.1093/jrr/rrw012 · Cited by 116
Genetic regulation of cell function in response to iron overload or chelation
Templeton, D. M., & Liu, Y. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00497-x · Cited by 112
van de Sluis, B., Muller, P., Duran, K., Chen, A., Groot, A. J., Klomp, L. W., Liu, P. P., & Wijmenga, C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01932-06 · Cited by 105
Regulation of iron pathways in response to hypoxia
Chepelev, N. L., & Willmore, W. G. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.023 · Cited by 106
Iron and its sensitive balance in the cell
Freitas, J. M. D., & Meneghini, R. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00066-5 · Cited by 101
miR-20a regulates expression of the iron exporter ferroportin in lung cancer
Babu, K. R., & Muckenthaler, M. U. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1362-3 · Cited by 101
Erez, N., Milyavsky, M., Eilam, R., Shats, I., Goldfinger, N., & Rotter, V. (2003) · PubMed · Cited by 97
Improved nuclear localization of DNA-binding polyamides
Nickols, N. G., Jacobs, C. S., Farkas, M. E., & Dervan, P. B. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1042 · Cited by 96
Howard, B. A., Furumai, R., Campa, M. J., Rabbani, Z. N., Vujašković, Ž., Wang, X., & Patz, E. F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1219 · Cited by 95
Microtissue size and hypoxia in HTS with 3D cultures
Asthana, A., & Kisaalita, W. S. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.004 · Cited by 95
Inflammation Triggers Chondrocyte Ferroptosis in TMJOA via HIF-1α/TFRC
Chen, B., Pathak, J. L., Lin, H., Guo, W. Q., Chen, W. J., Luo, G., Wang, L. J., Sun, X., Ding, Y., Li, J., et al. (2024) · Journal of Dental Research · doi:10.1177/00220345241242389 · Cited by 93
The Rb tumor suppressor is required for stress erythropoiesis
Spike, B. T., Dirlam, A., Dibling, B. C., Marvin, J., Williams, B. O., Jacks, T., & Macleod, K. F. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600432 · Cited by 92
A general map of iron metabolism and tissue-specific subnetworks
Hower, V., Mendes, P., Torti, F. M., Laubenbacher, R., Akman, S. A., Shulaev, V., & Torti, S. V. (2009) · Molecular BioSystems · doi:10.1039/b816714c · Cited by 97
The induction of HIF‐1 reduces astrocyte activation by amyloid beta peptide
Schubert, D. A., Soucek, T., & Blouw, B. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06712.x · Cited by 90
The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells
Herbison, C. E., Thorstensen, K., Chua, A. C. G., Graham, R. M., Leedman, P. J., Olynyk, J. K., & Trinder, D. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00649.2008 · Cited by 88
Guo, C., Hao, L.-J., Yang, Z., Chai, R., Zhang, S., Gu, Y., Gao, H., Zhong, M., Wang, T., Li, J., et al. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.03.016 · Cited by 87
Molecular Mechanisms and Regulation of Iron Transport
Chung, J., & Wessling‐Resnick, M. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609332 · Cited by 86
Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis
Timofeeva, O. A., Plisov, S. Y., Evseev, A. A., Peng, S., Jose-Kampfner, M., Lovvorn, H. N., Dome, J. S., & Perantoni, A. O. (2006) · Oncogene · doi:10.1038/sj.onc.1209742 · Cited by 85
Hypoxia-tropic Protein Nanocages for Modulation of Tumor- and Chemotherapy-Associated Hypoxia
Huang, X., Zhuang, J., Chung, S. W., Huang, B., Halpert, G., Negrón, K., Sun, X., Yang, J., Oh, Y., Hwang, P. M., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b05399 · Cited by 84
Guo, C., Zhang, Y., Wang, T., Zhong, M., Yang, Z., Hao, L.-J., Chai, R., & Zhang, S. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00104 · Cited by 80
Weinreb, O., Amit, T., Mandel, S. A., Kupershmidt, L., & Youdim, M. B. H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2929 · Cited by 80
Jian, J., Yang, Q., & Huang, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.271585 · Cited by 78
Ponti, C. D., Carini, R., Alchera, E., Nitti, M. P., Locati, M., Albano, E., Cairo, G., & Tacchini, L. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0107060 · Cited by 78
Self-citationRawat, P., Kumar, S., Sheokand, N., Raje, C. I., & Raje, M. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-058 · Cited by 75
Zheng, Q., Yang, H., Sun, L., Wei, R., Fu, X., Wang, Y., Huang, Y., Liu, Y., & Liu, W. J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105020 · Cited by 77
Hypoxia-Inducible Factor-1α Accumulation in the Brain after Experimental Intracerebral Hemorrhage
Jiang, Y., Wu, J., Keep, R. F., Hua, Y., Hoff, J. T., & Xi, G. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200206000-00007 · Cited by 71
Saletta, F., Rahmanto, Y. S., Noulsri, E., & Richardson, D. R. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.061028 · Cited by 73
Zhou, D., Herrick, D. J., Rosenbloom, J., & Chaqour, B. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01093.2004 · Cited by 72
A novel iron responsive element in the 3′UTR of human MRCKα
Čmejla, R., Petrák, J., & Čmejlová, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.155 · Cited by 67
Divalent metal transporter 1 is a hypoxia‐inducible gene
Qian, Z., Wu, X. M., Fan, M., Yang, L., Du, F., Yung, W., & Ke, Y. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22485 · Cited by 64
Relationships and distinctions in iron-regulatory networks responding to interrelated signals
Muckenthaler, M. U., Richter, A., Gunkel, N., Riedel, D., Polycarpou‐Schwarz, M., Hentze, S., Falkenhahn, M., Stremmel, W., Ansorge, W. J., & Hentze, M. W. (2003) · Blood · doi:10.1182/blood-2002-07-2140 · Cited by 62
Roudkenar, M. H., Halabian, R., Roushandeh, A. M., Nourani, M. R., Masroori, N., Ebrahimi, M., Nikogoftar, M., Rouhbakhsh, M., Bahmani, P., Jahanian‐Najafabadi, A., et al. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.08.019 · Cited by 62
Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis?
Lee, D. W., & Andersen, J. K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06470.x · Cited by 63
Characterization of glyceraldehyde-3-phosphate dehydrogenase as a novel transferrin receptor
Kumar, S., Sheokand, N., Mhadeshwar, M. A., Raje, C. I., & Raje, M. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.016 · Cited by 62
miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma
Babu, K. R., & Muckenthaler, M. U. (2019) · Scientific Reports · doi:10.1038/s41598-018-35947-7 · Cited by 60
Crépin, R., Goenaga, A.-L., Jullienne, B., Bougherara, H., Legay, C., Benihoud, K., Marks, J. D., & Poul, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0938 · Cited by 59
Galvez, T., Teruel, M. N., Heo, W. D., Jones, J. T., Kim, M. L., Liou, J., Myers, J. W., & Meyer, T. (2007) · Genome biology · doi:10.1186/gb-2007-8-7-r142 · Cited by 57
Nyga, A., Hart, A. J., & Tetley, T. D. (2015) · Nanotoxicology · doi:10.3109/17435390.2014.991430 · Cited by 56
Xu, X., Šuťák, R., & Richardson, D. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.041335 · Cited by 57
Therapeutic potential of iron chelators on osteoporosis and their cellular mechanisms
Zhang, J., Zhao, H., Yao, G., Qiao, P., Li, L., & Wu, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111380 · Cited by 56
Analysis of a “phase transition” from tumor growth to latency
Delsanto, P. P., Romano, A., Scalerandi, M., & Pescarmona, G. (2000) · Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics · doi:10.1103/physreve.62.2547 · Cited by 54
Iron Overload in Diabetic Retinopathy: A Cause or a Consequence of Impaired Mechanisms?
Ciudin, A., Hernández, C., & Simó, R. (2010) · Experimental Diabetes Research · doi:10.1155/2010/714108 · Cited by 56
Molecular regulation of cellular iron balance
Recalcati, S., Gammella, E., Buratti, P., & Cairo, G. (2017) · IUBMB Life · doi:10.1002/iub.1628 · Cited by 55
Self-citationTacchini, L., Fusar-Poli, D., Bernelli‐Zazzera, A., & Cairo, G. (2002) · Hepatology · doi:10.1053/jhep.2002.33997 · Cited by 52
Self-citationĆirović, A., Đenić, A., Clarke, B. L., Vassallo, R., Ćirović, A., & Landry, G. M. (2022) · Toxicology · doi:10.1016/j.tox.2022.153355 · Cited by 52
Biswas, S., Tapryal, N., Mukherjee, R., Kumar, R., & Mukhopadhyay, C. K. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.003 · Cited by 50
Sugahara, M., Tanaka, T., & Nangaku, M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108272 · Cited by 53
Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF
Wheeler, J. A., & Clinkenbeard, E. L. (2019) · Current Molecular Biology Reports · doi:10.1007/s40610-019-0110-9 · Cited by 48
Ozgür, B., Helms, H. C. C., Tornabene, E., & Brodin, B. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00297-6 · Cited by 49
Collins, J. F., Hu, Z., Ranganathan, P. N., Feng, D., Garrick, L. M., Garrick, M. D., & Browne, R. W. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00274.2007 · Cited by 43
Development of CRISPR/Cas Delivery Systems for In Vivo Precision Genome Editing
Chen, Y., & Yuan, P. (2023) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00279 · Cited by 48
Hypoxic preconditioning increases iron transport rate in astrocytes
Yang, L., Fan, M., Du, F., Gong, Q., Bi, Z. G., Zhu, Z. J., Zhu, L., & Ke, Y. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.004 · Cited by 44
Mandò, C., Tabano, S. M., Colapietro, P., Pileri, P., Colleoni, F., Avagliano, L., Doi, P., Bulfamante, G., Miozzo, M. R., & Cetin, I. (2010) · Placenta · doi:10.1016/j.placenta.2010.10.009 · Cited by 43
Campisi, A., Bonfanti, R., Raciti, G., Bonaventura, G., Legnani, L., Magro, G. G., Pennisi, M. A., Russo, G. L., Chiacchio, M. A., Pappalardo, F., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.01.003 · Cited by 42
RetractedLoss of the von Hippel Lindau Tumor Suppressor Disrupts Iron Homeostasis in Renal Carcinoma Cells
Alberghini, A., Recalcati, S., Tacchini, L., Santambrogio, P., Campanella, A., & Cairo, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500971200 · Cited by 41
Self-citationSpagnuolo, R. D., Recalcati, S., Tacchini, L., & Cairo, G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01208.x · Cited by 42
Self-citationRetractedEffect of metal ions on HIF-1α and Fe homeostasis in human A549 cells
Kang, G. S., Li, Q., Chen, H., & Costa, M. (2006) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2006.06.012 · Cited by 40
Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer
Lu, T., Tang, J., Shrestha, B., Heath, B. R., Li, H., Lei, Y. L., Ljungman, M. E., & Neamati, N. (2020) · Theranostics · doi:10.7150/thno.41792 · Cited by 40
Martínez‐Romero, R., Martínez‐Lara, E., Aguilar‐Quesada, R., Peralta, A., Oliver, F. J., & Siles, E. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21781 · Cited by 40
Hypoxia‐mediated Na‐K‐ATPase degradation requires von Hippel Lindau protein
Zhou, G., Dada, L. A., Chandel, N. S., Iwaï, K., Lecuona, E., Ciechanover, A. J., & Sznajder, J. I. (2007) · The FASEB Journal · doi:10.1096/fj.07-8369com · Cited by 41
Therapeutic Potential of Iron Chelators in Cancer Therapy
Richardson, D. R. (2002) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0593-8_12 · Cited by 40
Imanishi, Y., Hu, B., Xiao, G., Yao, X., & Cheng, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.235689 · Cited by 38
Unconventional endocytosis and trafficking of transferrin receptor induced by iron
Gammella, E., Lomoriello, I. S., Conte, A., Freddi, S., Alberghini, A., Poli, M., Sigismund, S., Cairo, G., & Recalcati, S. (2020) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-02-0129 · Cited by 37
Self-citation
Metadata
- Authors
- Bianchi, L., Tacchini, L., & Cairo, G.
- Affiliations
- University of Milan (IT)
- Corresponding author
- Cairo, G.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-11-01
- Volume
- 27
- Issue
- 21
- Pages
- 4223-4227
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC148697
- OpenAlex
- W2130304025
- Cited by
- 189
- References
- 33
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 7 · 2023: 12 · 2022: 9 · 2021: 12 · 2020: 8 · 2019: 5 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 4 · 2013: 7 · 2012: 6
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nucleic Acids Research (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Consiglio Nazionale delle Ricerche
- Ministero dell'Università e della Ricerca
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- HIF-1, transferrin receptor, iron chelation, deferoxamine, iron deficiency, hypoxia response element, transcriptional regulation, HIF-1α, hepatoma cells, iron absorption, gene expression
- MeSH terms
- Iron Deficiencies, Animals, Base Sequence, Cobalt, Deferoxamine, DNA, DNA-Binding Proteins, Carcinoma, Hepatocellular, Humans, Iron, Iron Chelating Agents, Mutation, Nuclear Proteins, Promoter Regions, Genetic, Receptors, Transferrin, Transcription Factors, Transcription, Genetic, Transfection, Tumor Cells, Cultured, Transcriptional Activation, Cell Hypoxia, Response Elements, Mice, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review